|
Market Cap (6-Jul) $43,777,552 (0th) |
Close (30-Jun) $0.300 |
Volume (30-Jun) 160,000 |
Shortsold (19-Jun) 3,649,691 (0.81%) (242nd) |
|
52w High $0.325 |
52w Low $0.082 |
P/E - |
EPS -0.03 |
MAP released this announcement to the ASX on 28 June 2022, 9:38. The announcement is marked as price sensitive, and is 2 page(s) in length and 186.84kb in size.
You can view all announcements from MAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, MAP was 0.000% short sold according to ASIC data. It was ranked the 643rd most shorted stock on the ASX. It is now ranked as the 242nd most shorted stock on the ASX with 0.815% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from MAP | |
|---|---|
| Notification of cessation of securities - MAP | 30 June 2023, 17:06 |
| Microba Commences Phase I Clinical Trial for IBD Therapeutic | 28 June 2023, 9:04 |
| MRFF Grant Awarded to QUT, In Collaboration With Microba | 27 June 2023, 11:17 |
| G42 Healthcare Partnership Commences Operation | 28 June 2022, 9:38 |
| Next Generation Product Released to Health Professionals | 23 June 2022, 9:11 |
| Application for quotation of securities - MAP | 15 June 2022, 9:01 |
| Microba & Ginkgo Commence Therapeutics Program | 8 June 2022, 9:08 |
You must be logged in to post a reply.
